Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Michael O'Riordan

April 15, 2019

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Daily News

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

Michael O'Riordan

February 13, 2017

Presentation TCT 2016

2016 DAPT Update: Evidence and Guidelines

Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla

November 01, 2016

Presentation TCT 2016

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla

October 30, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Egos and Experience: Personalized Risk Assessment Works, but Entrenched Beliefs Hinder Implementation

L.A. McKeown

June 13, 2016

News Daily News

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

Yael L. Maxwell

July 31, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Daily News

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Yael L. Maxwell

July 31, 2015

Advertisement

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

‘Misalignment’ Exists Between What Concerns Patients and Physicians Most After PCI

2016 DAPT Update: Evidence and Guidelines

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

The Bioresorbable Stent Story So Far: What Promise? What Price?

Egos and Experience: Personalized Risk Assessment Works, but Entrenched Beliefs Hinder Implementation

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

En Pacientes IAM, la Ventaja Precoz de Calidad de Vida de los SLF sobre los SMD Desaparece el cabo de 1 Año

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content